|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.50 USD | -2.75% |
|
-1.05% | -4.53% |
| Market Cap | 4.49B 3.94B 3.65B 3.36B 6.35B 430B 6.47B 43.47B 17.05B 211B 16.86B 16.49B 729B | P/E 2026 * |
68.2x | P/E 2027 * | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.53B 3.09B 2.86B 2.64B 4.98B 337B 5.08B 34.13B 13.39B 166B 13.24B 12.95B 572B | EV / Sales 2026 * |
2.84x | EV / Sales 2027 * | 2.37x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | -2.75% | ||
| 1 week | -1.05% | ||
| Current month | +0.79% | ||
| 1 month | +19.92% | ||
| 3 months | +18.83% | ||
| 6 months | -3.63% | ||
| Current year | -4.53% |
| 1 week | 25.3 |  | 26.51 |
| 1 month | 20.84 | | 27.31 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 33.99 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-26 | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 05-29 | Baker Bros. Advisors LP
| Free | Company | 101,260 | 0.0591% | |
| 05-29 | Fiscal year | Director | 41,529 | 0.0243% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.75% | -1.05% | +16.49% | -1.16% | 4.49B | |
| +0.44% | +1.41% | +4.25% | +10.81% | 50.73B | |
| -1.57% | -3.18% | +379.41% | +593.37% | 39.73B | |
| -0.14% | +0.77% | +29.61% | -5.50% | 34.69B | |
| +1.76% | -1.78% | +20.55% | +53.38% | 33.21B | |
| -0.06% | -4.63% | +2.94% | +31.65% | 26.76B | |
| -1.93% | -1.01% | - | - | 16.8B | |
| -1.49% | -6.18% | +65.50% | +120.53% | 15.37B | |
| +0.78% | +1.16% | +15.53% | +17.32% | 13.78B | |
| -0.97% | -2.83% | +11.09% | -33.29% | 12.85B | |
| Average | -0.62% | -0.78% | +60.60% | +87.46% | 24.84B | |
| Weighted average by Cap. | -0.28% | -0.35% | +79.95% | +121.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.09B 1.01B 927M 1.75B 119B 1.79B 12.01B 4.71B 58.32B 4.66B 4.56B 201B | 1.4B 1.22B 1.13B 1.04B 1.97B 134B 2.01B 13.51B 5.3B 65.58B 5.24B 5.12B 226B |
| Net income | 65.75M 57.67M 53.42M 49.15M 92.96M 6.29B 94.77M 637M 250M 3.09B 247M 242M 10.67B | 134M 117M 109M 99.97M 189M 12.8B 193M 1.29B 508M 6.29B 502M 491M 21.71B |
| Net Debt | -965M -846M -784M -721M -1.36B -92.32B -1.39B -9.34B -3.66B -45.34B -3.62B -3.54B -157B | -1.18B -1.03B -956M -880M -1.66B -113B -1.7B -11.4B -4.47B -55.33B -4.42B -4.32B -191B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | $25.50 | -2.75% | 1,562,769 |
| 10/07/26 | $26.22 | -0.72% | 1,442,787 |
| 09/07/26 | $26.41 | +1.58% | 1,801,279 |
| 08/07/26 | $26.00 | -0.76% | 1,551,853 |
| 07/07/26 | $26.20 | +1.67% | 1,674,460 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
